antiviral news
Press Releases in the global landscape
Jul 10, 2025
Most COVID-19 Drugs Fall Short, Meta-Analysis Confirms
A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to-moderate COVID-19 with moderate certainty.
Read More »
Jun 30, 2025
Shionogi files in Japan to expand pediatric use of COVID-19 antiviral
Japanese drugmaker Shionogi has filed a supplemental application in Japan to broaden the use of its oral antiviral Xocova (ensitrelvir), aiming to include children as young as six who weigh at least 20 kilograms.
Read More »
Jun 30, 2025
Shionogi Submits Supplemental New Drug Application for Ensitrelvir in Japan for the Treatment of COVID-19 in Pediatric Patients Aged 6 Years and Older
Shionogi Submits Supplemental New Drug Application for Ensitrelvir in Japan for the Treatment of COVID-19 in Pediatric Patients Aged 6 Years and Older.
Read More »
Jun 28, 2025
The Ministry of Health clarified the recommendations for the treatment of coronavirus
The Ministry of Health recommends starting antiviral therapy as early as possible, no later than 7-8 days from the onset of symptoms, which refers to etiotropic treatment (aimed at eliminating the cause of the disease - ed.).
Read More »
Jun 18, 2025
Shinpoong Pharm secures European patent for Pyramax as Covid-19 treatment
Shinpoong Pharmaceutical said Tuesday that it received a decision from the European Patent Office (EPO) to grant a patent for Pyramax (pyronaridine phosphate-artesunate), which was approved for treating malaria last Friday.
Read More »
Jun 2, 2025
Pfizer taps GC Biopharma to distribute Covid-19 pill in Korea
GC Biopharma began distributing Pfizer’s oral Covid-19 antiviral Paxlovid in Korea this month, marking a complete shift from government-led to private sector-led supply starting in July. The Korean drugmaker said Monday it signed a co-promotion and distribution deal with Pfizer Korea.
Read More »